| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Nexans: Proposed appointment to the Board of Directors at the Annual General Meeting on May 21st, 2026: Thierry Fournier candidate director - Appointed censor with immediate effect | ||
| Fr | Draft resolutions of the Annual General Meeting of Akcine prekybos bendrove "APRANGA" shareholders to be held on 30th April 2026 | ||
| Fr | Sodexo SA: Sodexo - Monthly disclosure on share capital and voting rights on March 31, 2026 | ||
| Fr | Touax: share capital and voting rights at 31032026 | ||
| Fr | Vilkyskiu Pienine: Notice on the Convened Ordinary General Meeting of Shareholders of Vilkyškiu pienine AB | ||
| Fr | VALEO SE: Valeo - Implementation of the share buy-back program | ||
| Fr | Dassault Aviation: Total number of shares and voting rights - 31 03 26 | ||
| Fr | AS LHV Group: LHV Group's own share acquisition transactions | ||
| Fr | EPSO-G UAB: EPSO-G has approved the new composition of Energy Cells Board | ||
| Fr | Navient Corporation: Navient to announce first quarter 2026 results, host earnings webcast April 29 | ||
| Fr | HII Redelivers USS New Jersey (SSN 796) from Post-Shakedown Availability at Newport News Shipbuilding | ||
| Fr | Liberty Gold Corp.: Liberty Gold Advances Black Pine Permitting with Publication of a Federal Notice of Intent | ||
| Fr | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces Changes to Board of Directors | ||
| Fr | Notice of the Annual General Meeting of Akcine prekybos bendrove "APRANGA" shareholders | ||
| Fr | Bicara Therapeutics Inc.: Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | MBX Biosciences, Inc.: MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Lotus Technology Inc.: Lotus Showcases Emira Racing Line Edition at the New York International Auto Show | ||
| Fr | Kura Oncology, Inc.: Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026 | ||
| Fr | Alta Equipment Group Announces Preferred Stock Dividend | ||
| Fr | BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | TELUS Digital: Multi-Sensor Data Labeling and AI Data Operations: What Enterprise AV Teams | ||
| Fr | Plug Power, Inc.: Plug Power CEO Jose Luis Crespo to Host Reddit AMA on April 16 | ||
| Fr | Wix.com, Ltd.: Wix Announces Final Results of Modified Dutch Auction Tender Offer |